| __timestamp | Evotec SE | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 7180000000 |
| Thursday, January 1, 2015 | 18343000 | 6704000000 |
| Friday, January 1, 2016 | 18108000 | 7194000000 |
| Sunday, January 1, 2017 | 17614000 | 9982000000 |
| Monday, January 1, 2018 | 35619000 | 9752000000 |
| Tuesday, January 1, 2019 | 58432000 | 9872000000 |
| Wednesday, January 1, 2020 | 63945000 | 13397000000 |
| Friday, January 1, 2021 | 72200000 | 12245000000 |
| Saturday, January 1, 2022 | 76642000 | 13548000000 |
| Sunday, January 1, 2023 | 57519000 | 30531000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, research and development (R&D) investments are pivotal. Over the past decade, Merck & Co., Inc. and Evotec SE have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, Merck's R&D spending surged by over 300%, peaking in 2023 with a staggering $30.5 billion, reflecting its commitment to innovation and drug development. In contrast, Evotec SE, a smaller player, increased its R&D investment by approximately 364%, reaching $57.5 million in 2023. This growth underscores Evotec's strategic focus on expanding its research capabilities. While Merck's investment dwarfs Evotec's, the latter's consistent growth highlights its ambition to compete in the global market. This comparison not only showcases the scale of investment but also the diverse approaches companies take to drive innovation.
Comparing Innovation Spending: Merck & Co., Inc. and Bristol-Myers Squibb Company
R&D Insights: How Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc. Allocate Funds
Merck & Co., Inc. vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Wave Life Sciences Ltd.
Comparing Innovation Spending: Merck & Co., Inc. and Galapagos NV
Research and Development Expenses Breakdown: Amgen Inc. vs Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and Evotec SE
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Evotec SE
Research and Development Expenses Breakdown: Viatris Inc. vs Evotec SE
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Evotec SE
Taro Pharmaceutical Industries Ltd. vs Evotec SE: Strategic Focus on R&D Spending